Clinical Trial Update: Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of zibotentan and dapagliflozin in adults with type 2 diabetes and elevated albuminuria has completed. The study focu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Zibotentan (zibotentan)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Chronic Kidney Diseases | Phase 2 | Status: COMPLETED